AI assistant
Formation Metals Inc. — Management Reports 2023
Aug 1, 2023
48467_rns_2023-07-31_5ff242e6-3959-40e2-8d39-5887dcd8cf9b.pdf
Management Reports
Open in viewerOpens in your device viewer
The effective date of this report is July 31, 2023
Management Discussion & Analysis:
Management's discussion and analysis ("MD&A") provides a detailed analysis of the results and financial condition of Formation Metals Inc. (the "Company" or "Formation") for the year ended March 31, 2023. The following management discussion and analysis, prepared as of July 31, 2023, should be read together with the financial statements for the year ended March 31, 2023 with the related notes attached thereto and the audited financial statements for the year ended March 31, 2023 with the related notes attached thereto, prepared in accordance with International Financial Reporting Standards ("IFRS"). The MD&A supplements, but does not form part of the financial statements. Management is responsible for the preparation of the financial statements and the MD&A for the year ended March 31, 2023. News releases and previous filings may be found on SEDAR at www.sedar.com.
Description of Business:
The Company was incorporated on March 1, 2022 under the laws of British Columbia. For the year ended March 31, 2023, the Company is a wholly-owned subsidiary of Usha Resources Ltd. ("USHA"). The Company's head office address is 1575 Kamloops Street, Vancouver BC, V5K 3W1, Canada. The registered and records office address is 400 – 1681 Chestnut Street, Vancouver BC, V7Y 1G5, Canada.
The Company's principal business activities include the acquisition and exploration of mineral property assets. On March 10, 2022, the Company entered into an Arrangement Agreement (the "Arrangement") with USHA to transfer the Nicobat Nickel-Copper-Cobalt property (the "Property") to the Company whereby USHA shareholders will be issued one (1) share of the Company with respect to every five (5) shares of USHA owned on the share distribution record date (the "Share Distribution Record Date"), which was determined by USHA's Board of Directors to be April 12, 2023. Pursuant to the arrangement agreement and on the payable date of April 20, 2023, USHA completed the transfer of the Property and distributed 9,480,476 common shares of the Company to the USHA shareholders on a pro rata basis.
Forward Looking Statements:
This Management Discussion and Analysis contains certain forward-looking statements and information relating to Formation that is based on the beliefs of the Company, or management, as well as assumptions made by and information currently available to the Company or management. When used in this document, the words "anticipate", "believe", "estimate", "expect", 'implied", "intend" and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted and the recent
outbreak of an epidemic or a pandemic, e.g., the novel coronavirus (COVID-19). Should one or more of these risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, implied, expected or intended. In each instance, forward-looking information should be considered in the light of the accompanying meaningful cautionary statements herein. Formation cautions that forward-looking statements involve risk and uncertainty.
Overall Performance
The Company does not generate revenues from operations. The Company's net loss for the year ended March 31, 2023 was $119,108.
Working capital deficiency as at March 31, 2023 was $119,107 (March 31, 2022: $nil), and comprised cash of $ $2,005 (March 31, 2022: $nil), receivables of $nil (March 31, 2022: $1), and accounts payable and accrued liabilities of $121,112 (March 31, 2022: $nil).
Summary of Exploration and Corporate Activities
During the year ended March 31, 2023, the Company issued:
i. 1 common share for nominal consideration.
Financial Instruments
IFRS 9 establishes three primary measurement categories for financial assets: fair value through profit and loss ("FVTPL"), fair value through other comprehensive income ("FVOCI") and amortized cost. The basis for classification depends on the entity's business model and the contractual cash flow characteristics of the instrument.
The Company determines the classification of its financial instruments at initial recognition. Upon initial recognition, a financial asset is classified as measured at: amortized cost, fair value through profit and loss ("FVTPL"), or fair value through other comprehensive income (loss) ("FVOCI"). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. A financial liability is classified and measured at amortized cost or FVTPL.
A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as FVTPL:
- it is held within a business model whose objective is to hold assets to collect contractual cash flows; and
- its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as FVTPL:
- it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and
- its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
An equity investment that is held for trading is measured at FVTPL. For other equity investments that are not held for trading, the Company may irrevocably elect to designate them as FVOCI. This election is made on an investment-by-investment basis.
All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. This includes all derivative financial assets. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.
Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or the Company has elected to measure them at FVTPL.
The Company classifies its financial instruments as follows:
| Asset or LiabilityClassificationCashAmortized costReceivablesAmortized costAccounts payable and accrued liabilitiesAmortized cost | IFRS 9 |
|---|---|
A fuller description of financial instruments is provided in Note 4 to the audited financial statements for the year March 31, 2023.
Recent Accounting Pronouncements
Certain new standards, interpretations, amendments and improvements to existing standards were issued by the IASB or International Financial Reporting Interpretations Committee.
During the period ended March 31, 2023, the Company was not required to, and has not adopted any new standards, interpretations, amendments and improvements to existing standards which had a material impact on the Company's condensed interim financial statements. The Company also does not expect the adoption of any currently announced new standards, interpretations, amendments and improvements to existing standards to have a material impact on the Company's condensed interim financial statements.
Summary of Quarterly Results & Results of Operations
During the period ended March 31, 2023, the Company did not perform any significant operations. The Company's financial statements are prepared in accordance with IFRS applicable to interim financial statements and are expressed in Canadian dollars.
Discussion of Operations for the year ended March 31, 2023
Loss and comprehensive loss for the year ended March 31, 2023, was $119,108 of which $52,194 was spent on audit, accounting and legal fees.
Liquidity, Capital Resources and Capital Expenditures
As at March 31, 2023, the Company's working capital deficiency, defined as current assets less current liabilities, was ($119,107) (March 31, 2022: $nil). The Company's ability to continue as a going concern is dependent upon its ability to raise additional capital. The factors considered by management are disclosed in Note 1 of the financial statements. The successful completion of such financing is not guaranteed, and depends on a number of factors, including the general sentiment in the capital markets, the strength of commodities prices and the strength of the local and global economies.
Contractual Obligations
The Company has no off-balance sheet arrangements.
Off-balance sheet arrangements
The Company has no off-balance sheet arrangements.
Financial risk factors
The Company's risk exposures and the impact on the Company's financial statements are summarized below.
Credit risk
Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and interest receivable. The Company limits its exposure to credit loss by placing its cash and G.I.C.'s with major financial institutions.
Liquidity risk
The Company's approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. In order to meet future obligations as they become due, the Company need to access funding from the issuance of equity securities, the exercise of stock options or through other sources. The Company's access to financing is uncertain and there is no assurance of continued access to equity funding.
Market risk
Market risk is the risk of loss that may arise from changes in market factors such as interest rates, foreign exchange rates and commodity and equity prices.
a) Interest rate risk
The Company is exposed to interest rate risk to the extent that the cash maintained at the financial institutions is subject to a floating rate of interest. The interest rate risks on cash and on the Company's obligations are not considered significant.
b) Foreign currency risk
The Company is exposed to foreign currency risk on fluctuations related to cash, receivables and accounts payable and accrued liabilities that are denominated in a foreign currency. As at March 31, 2023, the Company did not have any accounts in foreign currencies and considers foreign currency risk insignificant.
c) Price risk
Equity price risk is defined as the potential adverse impact on the Company's earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements and the stock market to determine the appropriate course of action to be taken by the Company.
The Company's business and operations could be adversely affected by the outbreak of an epidemic or a pandemic or other health crises, e.g., COVID-19. Global government actions, along with market uncertainty could cause an economic slowdown resulting in a decrease in the demand for metals and have a negative impact on metal prices, as well as possible disruptions to global supply chains. While these effects are expected to be temporary, the duration of the business disruptions internationally and related financial impact cannot be reasonably estimated at this time.
Related Party Transactions
The aggregate amount of expenditures paid or payable to key management personnel consisting of directors, former directors or companies with common directors was as follows:
| Name of theKey managementpersonnel | Company's Name | Nature ofTransaction | Year endedMarch 31, 2023 | Year endedMarch 31, 2022 | ||
|---|---|---|---|---|---|---|
| Navin Varshney | Individual | Reimbursement | $ | 2,000 | $ | - |
| Deepak Varshney, CEO | Individual | Reimbursement | $ | 5 | $ | - |
| Holding Company | Usha Resources Ltd. | Reimbursement | $ | 107,607 | $ | - |
These transactions were in the normal course of operations and were measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties.
Outstanding Share Data
Authorized Capital
Unlimited common shares with no par value and unlimited preferred shares with no par value.
Issued and Outstanding Capital
1 common share was issued and outstanding as at March 31, 2023.
Subsequent Events
On April 20, 2023, pursuant to the arrangement agreement and on the payable date of April 20, 2023, USHA completed the transfer of the Property and distributed 9,480,476 common shares of the Company to the USHA shareholders on a pro rata basis.